ISZO Capital Management’s Global Cord Blood Corporation CO Stock Holding History

ISZO Capital Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-279,495	Closed	–	–	10
2023 Q1	$0	Hold	279,495	–	–	﹤0.01%	14
2022 Q4	$836K	Hold	279,495	–	–	11.17%	4
2022 Q3	$836K	Buy	+279,495	New	+$687K	1.43%	6
2022 Q1	–	Sell	-1,000	Closed	-$4K	–	8
2021 Q4	$4K	Buy	+1,000	New	+$4.25K	﹤0.01%	7

Other funds holding CO

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return

Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

ISZO Capital Management's CO Position: Q2 2023 in Review

ISZO Capital Management sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 279,495 shares.

ISZO Capital Management first reported a position in CO in Q4 2021 and held it in 4 quarters. The position peaked at $836K in Q3 2022. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

ISZO Capital Management reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
ISZO Capital Management sold 279,495 Global Cord Blood Corporation shares in Q2 2023.
ISZO Capital Management first reported a position in Global Cord Blood Corporation in Q4 2021 and held it in 4 quarters.
ISZO Capital Management's Global Cord Blood Corporation position peaked at $836K in Q3 2022.
6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on ISZO Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.